Remove Licensing Remove Pharmaceuticals Remove Programming
article thumbnail

What is NLP? Natural language processing explained

CIO Business Intelligence

They integrate with Slack, Microsoft Messenger, and other chat programs where they read the language you use, then turn on when you type in a trigger phrase. That’s why critics say these programs are always listening; if they weren’t, they’d never know when you need them. NLTK is offered under the Apache 2.0 Amazon Comprehend.

Course 355
article thumbnail

Univ. of Wash.-spinout Icosavax raises $100M to fund vaccine development technology

GeekWire

Icosavax creates virus-like particles with technology licensed from the University of Washington’s Institute for Protein Design. The company launched its COVID program in October, supported in part by $10 million from the Bill & Melinda Gates Foundation. Icosavax Photo).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

4 stories all CIOs should be able to tell

CIO Business Intelligence

Senior executives in some industries—technology, finance, and pharmaceuticals—are most comfortable making assertions and sharing facts, Keeley notes. I’m also licensed as one of about 60 storytellers worldwide to deliver workshops and training programs from Anecdote.com , which also shares a lot of great free resources.

article thumbnail

4 stories all CIOs should be able to tell

CIO Business Intelligence

Senior executives in some industries—technology, finance, and pharmaceuticals—are most comfortable making assertions and sharing facts, Keeley notes. I’m also licensed as one of about 60 storytellers worldwide to deliver workshops and training programs from Anecdote.com , which also shares a lot of great free resources.

article thumbnail

Alpine raises $91M to fuel the Seattle biotech’s clinical trials for lupus and cancer

GeekWire

The funding will fuel Alpine’s program developing ALPN-303, designed to treat lupus and other inflammatory diseases. That payment is part of a licensing deal inked last year with the pharmaceutical giant for clinical testing of another immune-modulating agent, ALPN-101, for lupus. million shares of common stock and 3.2

article thumbnail

Merck’s multi-billion dollar bet on Seattle Genetics sparks hope for breast cancer treatments

GeekWire

based biotechnology company struck a deal with Merck in which the pharmaceutical powerhouse will provide a $600 million upfront payment and make a $1 billion equity investment to continue development of treatments for breast cancer. (Seattle Genetics Photo). Merck will own about 2.9

article thumbnail

Seattle biotech startup AltPep raises $23.1M to tackle Alzheimer’s and related diseases

GeekWire

The UW has licensed the exclusive rights of this intellectual property to the startup. This funding will allow us to build upon our promising preliminary data demonstrating detection of Alzheimer’s disease at its earliest stages and further our preclinical therapeutic program,” Daggett said in a statement.